Hodgkin's lymphoma Posts - Page 2 of 33 on Medivizor
Navigation Menu

Hodgkin’s lymphoma Posts on Medivizor

The impact of checkpoint blockade therapy in making Hodgkin lymphoma sensitive to future treatment

The impact of checkpoint blockade therapy in making Hodgkin lymphoma sensitive to future treatment

Posted by on Aug 16, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell The study evaluated whether exposure to checkpoint blockade therapy (CBT) can make relapsed/refractory (R/R) Hodgkin lymphoma (HL) sensitive to further treatments. The main finding was that CBT may make patients with R/R-HL responsive to further treatments. Some background While a large percentage of patients with HL can ve cured with...

Read More

Allogeneic stem cell transplant in patients with classic Hodgkin lymphoma who have been treated with immune checkpoint inhibitors

Allogeneic stem cell transplant in patients with classic Hodgkin lymphoma who have been treated with immune checkpoint inhibitors

Posted by on Aug 16, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to investigate the safety and effectiveness of allogeneic stem cell transplantation (alloSCT) after immune checkpoint inhibitor (ICI) treatment in patients with classic Hodgkin lymphoma (cHL).   This study concluded that this treatment is safe and has very good outcomes in these...

Read More

The effects of a second autologous stem cell transplantation in patients with relapsed/refractory Hodgkin lymphoma after a first transplant

The effects of a second autologous stem cell transplantation in patients with relapsed/refractory Hodgkin lymphoma after a first transplant

Posted by on Aug 9, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell The study evaluated the outcomes of second autologous stem cell transplantation (ASCT2) in patients with relapsed/refractory Hodgkin lymphoma (r/r-HL) after a first transplantation (ASCT1). The main finding was that ASCT2 was safe and relatively effective in such patients. Some background ASCT replaces cancerous bone marrow with healthy...

Read More

COVID-19 with Cancer

COVID-19 with Cancer

Posted by on Jul 31, 2020 in Blog, Breast cancer, Colorectal cancer, Coronavirus / COVID-19, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 3 comments

Recent research presented at a virtual meeting of the American Association for Cancer Research 1 indicates the need for greater care and continued social distancing for those who are in treatment for cancer and – in one study that was presented – those who have a recent history of cancer (the research looked at people from 2015 to the...

Read More

Evaluating long-term pembrolizumab for relapsed Hodgkin lymphoma

Evaluating long-term pembrolizumab for relapsed Hodgkin lymphoma

Posted by on Jul 26, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study looked at the effect of pembrolizumab (Keytruda) to treat classical Hodgkin lymphoma (cHL) which had relapsed after previous treatments including brentuximab vedotin (Adcetris). It found that pembrolizumab was effective for these patients. Some background cHL is typically treated with chemotherapy, and sometimes with radiation...

Read More

Stanford V chemotherapy and limited filed irradiation for patients with unfavorable risk stage I-II classic Hodgkin lymphoma

Stanford V chemotherapy and limited filed irradiation for patients with unfavorable risk stage I-II classic Hodgkin lymphoma

Posted by on Jul 19, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to investigate the long-term outcomes for patients with stage I-II classic Hodgkin lymphoma and unfavorable risk who were treated with Stanford V combined modality therapy.  This study concluded that the long-term outcomes for these patients were favorable and comparable to other standard...

Read More

Managing patients with limited-stage Hodgkin lymphoma by brentuximab vedotin based therapy

Managing patients with limited-stage Hodgkin lymphoma by brentuximab vedotin based therapy

Posted by on Jul 5, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell The study evaluated if brentuximab-vedotin (BV; Adcetris) consolidation therapy can reduce the use of radiation therapy (RT) in patients with limited-stage (LS) Hodgkin lymphoma (HL). The authors found that BV consolidation achieved good outcomes in such patients when given after ABVD therapy. Some background HL is a cancer of the...

Read More

How does ABVD chemotherapy affect the fertility of female patients with Hodgkin lymphoma?

How does ABVD chemotherapy affect the fertility of female patients with Hodgkin lymphoma?

Posted by on Jun 27, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined if ABVD chemotherapy impacted fertility in female patients with Hodgkin lymphoma (HL). The authors found that ABVD reduced the levels of one of the fertility hormones and the type of fertility treatment patients opted for was not affected by ABVD. Some background Many patients with HL are young and fertility...

Read More

How does COVID-19 affect patients with cancer undergoing chemotherapy?

How does COVID-19 affect patients with cancer undergoing chemotherapy?

Posted by on Jun 21, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined how COVID-19 infection affects patients with cancer undergoing chemotherapy and the role of other factors in COVID-19 complications. The results showed that patients with advanced age and other medical conditions had a higher risk of COVID-19 complications but chemotherapy treatment did not need to be stopped. Some...

Read More

Impact of graft cryopreservation on allogeneic hematopoietic stem cell transplant outcomes using post-transplant cyclophosphamide

Impact of graft cryopreservation on allogeneic hematopoietic stem cell transplant outcomes using post-transplant cyclophosphamide

Posted by on Jun 21, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to compare outcomes of allogeneic hematopoietic stem cell transplant (alloHSCT) using cryopreserved (frozen) and fresh grafts in patients with blood cancers who received post-transplant cyclophosphamide (Cytoxan).   This study concluded that cryopreservation (CP) does...

Read More